Calvary The Japara Healthcare Board today unanimously recommended the Calvary proposal to shareholders which, if approved, will see Calvary acquire 100% of the Japara shares, at $1.40 a share, via a Scheme of Arrangement. The Scheme implies an equity value of approximately $380 million. It is subject to Japara shareholders’ approval by the requisite majorities at the Scheme Meeting expected to be held in October 2021. Martin Bowles, Calvary National CEO said: “Over the next few months, Japara will seek broad shareholder and court approval. “While we still have a way to go, this is very encouraging and another step to further establish our integrated care model across residential, community and hospital services.